Article
Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Cancer science - 1 Jul 2020
Onuki Mamiko, Matsumoto Koji, Iwata Takashi, Yamamoto Kasumi, Aoki Yoichi, Maenohara Shoji, Tsuda Naotake, Kamiura Shoji, Takehara Kazuhiro, Horie Koji, Tasaka Nobutaka, Yahata Hideaki, Takei Yuji, Aoki Yoichi, Kato Hisamori, Motohara Takeshi, Nakamura Keiichiro, Ishikawa Mitsuya, Kato Tatsuya, Yoshida Hiroyuki, Matsumura Noriomi, Nakai Hidekatsu, Shigeta Shogo, Takahashi Fumiaki, Noda Kiichiro, Yaegashi Nobuo, Yoshikawa Hiroyuki
Abstract excerpt
To obtain baseline data for cervical cancer prevention in Japan, we analyzed human papillomavirus (HPV) data from 5045 Japanese women aged less than 40 years and diagnosed with cervical abnormalities at 21 hospitals during 2012-2017. These included cervical intraepithelial neoplasia grade 1 (CIN1, n = 573), CIN2-3 (n = 3219), adenocarcinoma in situ (AIS, n = 123), and invasive cervical cancer (ICC, n = 1130). The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
